Carlos V. Paya - Jun 6, 2024 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role: Director
Signature: Carlos V. Paya, by /s/ Peter N. Efremenko, Attorney-In-Fact
Stock symbol: PCVX
Transactions as of: Jun 6, 2024
Transactions value $: $0
Form type: 4
Date filed: 6/10/2024, 04:05 PM
Previous filing: Nov 9, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PCVX	Common Stock	Award	$0	+1.55K	+62%	$0.00	4.05K	Jun 6, 2024	Direct	F1
holding	PCVX	Common Stock						3.13K	Jun 6, 2024	By Family Trust	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PCVX	Stock Option (right to buy)	Award	$0	+7.25K		$0.00	7.25K	Jun 6, 2024	Common Stock	7.25K	$72.51	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will fully vest on the earlier of June 6, 2025 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date.
F2	Shares are held directly by a trust for the sole benefit of the Reporting Person.
F3	The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 6, 2025 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date.